PE20040973A1 - Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales - Google Patents

Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales

Info

Publication number
PE20040973A1
PE20040973A1 PE2004000029A PE2004000029A PE20040973A1 PE 20040973 A1 PE20040973 A1 PE 20040973A1 PE 2004000029 A PE2004000029 A PE 2004000029A PE 2004000029 A PE2004000029 A PE 2004000029A PE 20040973 A1 PE20040973 A1 PE 20040973A1
Authority
PE
Peru
Prior art keywords
decongestive
nsaid
composition
dose
decongestives
Prior art date
Application number
PE2004000029A
Other languages
English (en)
Spanish (es)
Inventor
Roger Glen Berlin
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32682029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20040973(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20040973A1 publication Critical patent/PE20040973A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PE2004000029A 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales PE20040973A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43434202P 2002-12-18 2002-12-18

Publications (1)

Publication Number Publication Date
PE20040973A1 true PE20040973A1 (es) 2004-12-14

Family

ID=32682029

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2004000029A PE20040973A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales
PE2008000932A PE20081072A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2008000932A PE20081072A1 (es) 2002-12-18 2004-01-05 Composiciones de anti-histaminicos, descongestivos, antitusivos y drogas anti-inflamatorios no esteroidales

Country Status (18)

Country Link
US (1) US7863287B2 (enExample)
EP (1) EP1572206B1 (enExample)
JP (1) JP2006515299A (enExample)
CN (2) CN1726035A (enExample)
AR (1) AR042543A1 (enExample)
AU (1) AU2003301188B2 (enExample)
CA (1) CA2508611C (enExample)
CL (1) CL2003002653A1 (enExample)
CO (1) CO5640087A2 (enExample)
ES (1) ES2468217T3 (enExample)
MX (1) MXPA05006331A (enExample)
NZ (1) NZ540289A (enExample)
PE (2) PE20040973A1 (enExample)
PT (1) PT1572206E (enExample)
RU (1) RU2322262C2 (enExample)
TW (1) TWI313598B (enExample)
WO (1) WO2004056320A2 (enExample)
ZA (1) ZA200504908B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007073702A2 (es) 2005-12-29 2007-07-05 Osmotica Corp. Comprimido multicapa con combinación de triple liberación
WO2008114280A1 (en) * 2007-03-21 2008-09-25 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
TR201107202T1 (tr) * 2008-11-11 2012-02-21 Berko �La� Ve K�Mya Sanay� A.�. İbuprofen, psödoefedrin ve klorfeniramin içeren bir farmasötik bileşim.
US8377475B2 (en) 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
WO2010078542A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
EP2853262B1 (en) * 2009-10-26 2016-11-30 Sephoris Pharmaceuticals, LLC Treatment of sunburn using analgesics and antihistamines
JP5777906B2 (ja) * 2010-02-26 2015-09-09 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
KR20130061148A (ko) * 2010-05-03 2013-06-10 티에스에이치 바이오팜 코포레이션 리미티드 고혈압 치료용 약학 조성물 및 방법
EP2595597B1 (en) * 2010-07-19 2017-09-13 Procaps S.A. Apparatus and process for encapsulating capsules or other solid dosage forms within capsules
JP5898964B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩を含有する医薬組成物
JP5898963B2 (ja) * 2011-01-12 2016-04-06 興和株式会社 ロキソプロフェン又はその塩含有の医薬組成物
US9216181B2 (en) * 2011-06-08 2015-12-22 Southwest Research Institute BMP-2 upregulating compounds for healing bone tissue and screening methods for selecting such compounds
ES2738659T3 (es) * 2013-03-12 2020-01-24 Hercules Llc Composición de polímero revestida con sílice co-procesada
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
CN107635549A (zh) * 2015-03-26 2018-01-26 杰奎琳·M·艾弗森 抑制与宿醉相关的症状的方法和组合物
CN104758935B (zh) * 2015-04-10 2017-11-21 海口世康药物研究有限公司 一种改善复方布洛芬制剂稳定性的组合物及其制备方法
AU2017331369B2 (en) 2016-09-26 2019-11-21 The Procter & Gamble Company Extended relief dosage form

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4585783A (en) * 1984-02-08 1986-04-29 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4985459A (en) * 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4522826A (en) * 1984-02-08 1985-06-11 Richardson-Vicks Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4683243A (en) * 1984-02-08 1987-07-28 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4755532A (en) * 1984-02-08 1988-07-05 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4906625A (en) * 1984-02-08 1990-03-06 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and metyhods of using same
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US5025019A (en) * 1984-04-09 1991-06-18 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
AU738274B2 (en) 1984-04-09 2001-09-13 Procter & Gamble Company, The Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4840962A (en) * 1984-04-09 1989-06-20 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4971785A (en) * 1988-03-14 1990-11-20 Spectrum Consumer Products Co., Inc. Non-alcoholic delivery system for orally ingestible active ingredients
US5288479A (en) * 1989-01-17 1994-02-22 Sterling Drug, Inc. Extrudable elastic oral pharmaceutical gel compositions and metered dose dispensers containing them and method of making and method of use thereof
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
AU662297B2 (en) * 1990-09-11 1995-08-31 Richardson-Vicks Inc. Method for providing improved analgesic effect
WO1992004022A1 (en) 1990-09-11 1992-03-19 Richardson Vicks Inc. Use of compositions containing 2-(6'-substituted-2'-naphthyl)-acetic acid derivatives for the treatment of respiratory disorders
US5196436A (en) * 1990-10-31 1993-03-23 The Procter & Gamble Company Dextromethorphan antitussive compositions
JPH06506684A (ja) 1991-04-01 1994-07-28 メルク　エンド　カンパニー　インコーポレーテッド イブプロフェン−充血除去剤配合物
ES2148175T3 (es) * 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
US5492689A (en) * 1991-11-19 1996-02-20 The Center For Innovative Technology Combined virustatic antimediator (COVAM) treatment of common colds
CA2084028A1 (en) 1991-11-27 1993-05-28 Harish B. Pandya Hot flu composition
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US6303632B1 (en) * 1992-09-03 2001-10-16 Sepracor Inc. Compositions for treating allergic and other disorders using norastemizole in combination with other active ingredients
CA2149317A1 (en) * 1992-12-21 1994-07-07 Richard Wilfred D'souza Compositions and method for providing improved analgesic effect
WO1994014476A1 (en) 1992-12-21 1994-07-07 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
JP3733140B2 (ja) * 1993-06-04 2006-01-11 ワーナー−ランバート・コンパニー 多重作用性風邪／鼻づまり製剤
US5466865A (en) * 1993-07-02 1995-11-14 Ibah, Inc. Neomorphic ibuprofen and methods of using same
CA2170485C (en) * 1993-09-07 2000-11-07 Sekhar Mitra Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
BR9407414A (pt) 1993-09-07 1996-11-12 Procter & Gamble Composições contendo um sal de aminoácido de agente antiinflamatório não-esteroide de ácido propiônico e pelo menos um descongestionante um expectorante um anti-histamina e um antitussivo
CN1060040C (zh) 1993-10-25 2001-01-03 默里尔药物公司 稳定的丁苯哌丁醇与布洛芬的药物组合物
US5560913A (en) * 1995-01-27 1996-10-01 The Procter & Gamble Company Pharmaceutical compositions
US5622723A (en) * 1995-02-03 1997-04-22 Eurand America, Incorporated Procedure for encapsulating chlorpheniramine
EP0841947A1 (en) * 1995-07-28 1998-05-20 The Procter & Gamble Company Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
US5766622A (en) * 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
US6210710B1 (en) * 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
US5869479A (en) * 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses
JP2001517626A (ja) 1997-09-19 2001-10-09 ザ、プロクター、エンド、ギャンブル、カンパニー 呼吸疾患を治療するための組成物及び方法
US6337091B1 (en) * 1997-10-27 2002-01-08 Temple University - Of The Commonwealth System Of Higher Education Matrix for controlled delivery of highly soluble pharmaceutical agents
AU1205799A (en) * 1997-10-29 1999-05-17 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6090411A (en) * 1998-03-09 2000-07-18 Temple University Monolithic tablet for controlled drug release
US6267986B1 (en) 1999-09-24 2001-07-31 Ranbaxy Laboratories Limited Process for the preparation of a controlled drug delivery system containing pseudoephedrine and a long acting antihistamine
WO2003024427A1 (en) * 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
JP2002316927A (ja) 2001-04-19 2002-10-31 Taisho Pharmaceut Co Ltd 感冒用組成物
WO2002096406A1 (en) 2001-05-25 2002-12-05 Ssp Co., Ltd. Medicinal compositions
WO2003089007A1 (en) 2002-04-22 2003-10-30 Adcock Ingram Intellectual Property (Proprietary) Limited Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu
JPWO2004048895A1 (ja) 2002-11-22 2006-03-23 財団法人くまもとテクノ産業財団 移動体ナビゲート情報表示方法および移動体ナビゲート情報表示装置
WO2005063219A2 (en) 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules

Also Published As

Publication number Publication date
JP2006515299A (ja) 2006-05-25
CN102406642B (zh) 2013-04-03
HK1166602A1 (en) 2012-11-02
WO2004056320A3 (en) 2004-09-23
CL2003002653A1 (es) 2005-04-22
TWI313598B (en) 2009-08-21
RU2322262C2 (ru) 2008-04-20
WO2004056320A2 (en) 2004-07-08
CN102406642A (zh) 2012-04-11
PT1572206E (pt) 2014-06-12
RU2005122403A (ru) 2006-01-20
AU2003301188A1 (en) 2004-07-14
TW200413004A (en) 2004-08-01
ZA200504908B (en) 2006-12-27
EP1572206A4 (en) 2007-07-18
AR042543A1 (es) 2005-06-22
CA2508611C (en) 2011-07-26
US20040186184A1 (en) 2004-09-23
CN1726035A (zh) 2006-01-25
MXPA05006331A (es) 2005-08-26
CA2508611A1 (en) 2004-07-08
ES2468217T3 (es) 2014-06-16
PE20081072A1 (es) 2008-08-15
US7863287B2 (en) 2011-01-04
EP1572206B1 (en) 2014-04-23
HK1078494A1 (en) 2006-03-17
AU2003301188B2 (en) 2009-07-02
CO5640087A2 (es) 2006-05-31
EP1572206A2 (en) 2005-09-14
NZ540289A (en) 2006-10-27

Similar Documents

Publication Publication Date Title
PE20040973A1 (es) Composiciones de anti-histaminicos, descongestivos y drogas anti-inflamatorias no esteroidales
HRP20200600T1 (hr) Tapentadol za sprječavanje i liječenje depresije i tjeskobe
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
ECSP055569A (es) Forma de dosificación de pramipexol en una dosis única diaria
AR066420A1 (es) Composicion farmaceutica suministrable oronasofaringeamente para la prevencion alivio / y o tratamiento de trastornos de miembros inquietos. uso.
AR032152A1 (es) Uso de una combinacion de compuestos terapeuticos organicos para la fabricacion de un medicamento, un agente terapeutico, y una composicion farmaceutica
BRPI0508342A (pt) formulações farmacêuticas
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
ECSP10010224A (es) Formulaciones líquidas de hormona luteinizante (lh).
JP2009541443A5 (enExample)
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
AR077284A1 (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
AR062167A1 (es) Sistema de administracion gastrorretentivo
UY30636A1 (es) Composision farmaceutica de liberacon modificada de un musculo relajante y un aine
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
HRP20231177T1 (hr) Kombinacija tvari za uporabu u regenerativnoj terapiji kod pacijenata sa šećernom bolesti tipa 1
PE20040670A1 (es) Nuevas composiciones farmaceuticas que contienen ambroxol y yoduro de isopropamida
CL2008003584A1 (es) Uso de la 10-[(3r)-1-azabiciclo]oct-3-ilmetil]-10-h-fenotiazina, o una de sus sales farmaceuticamente aceptables para la preparación de un medicamento util para prevenir o tratar la bronconeumopatia obstructiva.
BRPI0510855A (pt) medicamento em forma de pelìcula para ministração oral e uso de estriol e/ou de ésteres de estriol farmaceuticamente aceitáveis
AR067465A1 (es) Composicion farmaceutica que comprende la combinacion de un agente derivado benzisoxazolico y un agente benzodiazepinico
AR047684A1 (es) Composiciones de drogas descongestivas o anti-histaminicas y anti-inflamatorios no esteroides
AR066587A1 (es) Forma de dosificacion que comprende 10 - [( 3s))-1-azabiciclo[2.2.2]oct-3 -ilmetil]-10h-fenotiazina provista en forma adecuada para la administracion oral de una dosis diaria de 1 mg a 3 mg
UY31230A1 (es) Composición farmacéutica que comprende la combinación de un agente anticonvulsionante y un agente benzodiazepínico, indicada para el control y tratamiento de trastornos convulsivos y síndromes epilépticos.
Cetin Asenapine: A novel hope in the treatment of schizophrenia and manic and mixed episodes of bipolar I disorder
ECSP109908A (es) Administración transdérmica de (2s)-(4e)-n-metil-5-(3-(5-isopropoxipiridin) il)-4-penten-2-amina

Legal Events

Date Code Title Description
FC Refusal